Novo Nordisk A/S
NONOF
$49.45
-$0.07-0.14%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.19B | 3.13B | 4.03B | 4.10B | 4.03B |
| Total Depreciation and Amortization | 480.85M | 507.06M | 638.57M | 539.99M | 296.69M |
| Total Amortization of Deferred Charges | 49.57M | -- | -- | -- | 36.44M |
| Total Other Non-Cash Items | -6.71B | 4.36B | 810.61M | 1.15B | -4.55B |
| Change in Net Operating Assets | 3.17B | -776.96M | 723.30M | -2.32B | 1.94B |
| Cash from Operations | 1.19B | 7.22B | 6.20B | 3.47B | 1.76B |
| Capital Expenditure | -2.87B | -2.13B | -2.23B | -1.89B | -2.30B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -142.90K |
| Cash Acquisitions | 156.49M | -- | -- | -- | -11.65B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.96B | -281.49M | 62.82M | 952.03M | 911.93M |
| Cash from Investing | -6.67B | -2.42B | -2.17B | -941.31M | -13.04B |
| Total Debt Issued | 30.62B | 713.00M | 45.24B | 27.36B | 44.76B |
| Total Debt Repaid | -1.15B | -1.15B | -64.86B | -12.03B | -433.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | -1.39B | -7.49B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -2.61B | -- | -4.98B | 0.00 |
| Other Financing Activities | -- | -- | -26.78B | 26.78B | -- |
| Cash from Financing | 4.59B | -2.68B | -7.03B | 768.93M | 5.26B |
| Foreign Exchange rate Adjustments | 16.52M | 9.87M | -123.21M | -12.13M | 102.47M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -875.96M | 2.14B | -3.12B | 3.28B | -5.91B |